WallStSmart

Freeport-McMoran Copper & Gold Inc (FCX)vsWelltower Inc (WELL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Freeport-McMoran Copper & Gold Inc generates 125% more annual revenue ($26.42B vs $11.77B). WELL leads profitability with a 12.0% profit margin vs 10.3%. WELL appears more attractively valued with a PEG of 3.66. FCX earns a higher WallStSmart Score of 64/100 (C+).

FCX

Buy

64

out of 100

Grade: C+

Growth: 6.7Profit: 7.0Value: 2.7Quality: 6.0
Piotroski: 3/9Altman Z: 1.68

WELL

Buy

57

out of 100

Grade: C

Growth: 10.0Profit: 5.5Value: 2.0Quality: 6.5
Piotroski: 4/9Altman Z: 1.20
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

FCXSignificantly Overvalued (-36.5%)

Margin of Safety

-36.5%

Fair Value

$47.94

Current Price

$61.65

$13.71 premium

UndervaluedFair: $47.94Overvalued
WELLSignificantly Overvalued (-57.2%)

Margin of Safety

-57.2%

Fair Value

$132.26

Current Price

$214.63

$82.37 premium

UndervaluedFair: $132.26Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

FCX3 strengths · Avg: 9.0/10
EPS GrowthGrowth
154.0%10/10

Earnings expanding 154.0% YoY

Market CapQuality
$88.62B9/10

Large-cap with strong market position

Operating MarginProfitability
23.1%8/10

Strong operational efficiency at 23.1%

WELL3 strengths · Avg: 9.7/10
Revenue GrowthGrowth
38.3%10/10

Revenue surging 38.3% year-over-year

EPS GrowthGrowth
157.9%10/10

Earnings expanding 157.9% YoY

Market CapQuality
$150.32B9/10

Large-cap with strong market position

Areas to Watch

FCX4 concerns · Avg: 3.3/10
P/E RatioValuation
32.6x4/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.684/10

Distress zone — elevated risk

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
4.102/10

Expensive relative to growth rate

WELL4 concerns · Avg: 2.3/10
Return on EquityProfitability
3.7%3/10

ROE of 3.7% — below average capital efficiency

PEG RatioValuation
3.662/10

Expensive relative to growth rate

P/E RatioValuation
102.4x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.202/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : FCX

The strongest argument for FCX centers on EPS Growth, Market Cap, Operating Margin.

Bull Case : WELL

The strongest argument for WELL centers on Revenue Growth, EPS Growth, Market Cap. Revenue growth of 38.3% demonstrates continued momentum.

Bear Case : FCX

The primary concerns for FCX are P/E Ratio, Altman Z-Score, Piotroski F-Score.

Bear Case : WELL

The primary concerns for WELL are Return on Equity, PEG Ratio, P/E Ratio. A P/E of 102.4x leaves little room for execution misses.

Key Dynamics to Monitor

FCX profiles as a value stock while WELL is a growth play — different risk/reward profiles.

FCX carries more volatility with a beta of 1.32 — expect wider price swings.

WELL is growing revenue faster at 38.3% — sustainability is the question.

FCX generates stronger free cash flow (522M), providing more financial flexibility.

Bottom Line

FCX scores higher overall (64/100 vs 57/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Freeport-McMoran Copper & Gold Inc

BASIC MATERIALS · COPPER · USA

Freeport-McMoRan Inc., often called Freeport, is an American mining company based in the Freeport-McMoRan Center, in Phoenix, Arizona.

Visit Website →

Welltower Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Welltower Inc. is a real estate investment trust that invests in healthcare infrastructure.

Visit Website →

Want to dig deeper into these stocks?